Top Markets
#1 ADO Protocol ADO Protocol +194.13%
#2 GoPlus Security GoPlus Security +39.05%
#3 GAIB AID GAIB AID +24.67%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.18%
#5 Tutorial Tutorial +13.45%
#6 Verus Coin Verus Coin +13.11%
#7 o1.exchange o1.exchange +12.65%
#8 Pons Pons +12.63%
#9 SkyAI SkyAI +11.49%
#10 Status Status +11.24%
Coin of the day
ADO Protocol ADO Protocol
설정
언어
한국어
통화
USD
테마
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
주식 순위 #33546
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
주가
$0.11989842
시가총액
$7.42M
변동 (1일)
6.25%
변동 (1년)
179.27%
국가
AU
거래 Vectus Biosystems Limited (VBS)

카테고리

Healthcare
Vectus Biosystems Limited (VBS)의 주가 이력
최고 종가: $0.12 (2026-08-01 기준)

최저 종가: $1.09 (2016-02-01 기준)
Vectus Biosystems Limited의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -0.51%
2025 89.66%
2024 -76.86%
2023 -62.94%
2022 -37.77%
2021 -3.80%
2020 134.91%
2019 -5.17%
2018 -59.48%
2017 -8.31%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE